Invest1 publisher2 min readPublished
Amodei concedes that a coordinated AI slowdown may need government antitrust cover
Sam Altman endorsed the pacing proposal within a day and Elon Musk backed it too, while David Sacks says labs could slow voluntarily and Anatoly Yakovenko puts the motive at profitability at a $1 trillion market cap.
The Investor · Invest desk

What happened
- Anthropic's Dario Amodei published an essay, We Must Pace the Frontier, arguing that developers should slow the rate at which they improve model capabilities without stopping training or research.
- Sam Altman endorsed the idea in a Sept. 12 post, writing that he agrees with Amodei that the frontier needs pacing, and Elon Musk backed the proposal in a brief statement reported by Reuters.
- Solana co-founder Anatoly Yakovenko replied on Sept. 13 with a four-word post putting the motive at profitability at a $1 trillion market cap, without naming a company.
Compiled by The InvestorSomething wrong?How this is made
Why it matters
- constraint The coordination stage cannot be signed by the labs alone: an agreement among competitors to cap capability growth needs a narrow legal authorization before counsel clears anyone to sign it.
- cost Voluntary pacing bills the whole cost to whichever lab slows first while the others keep releasing; a coordinated requirement spreads that cost across everyone building at the frontier.
- exposure An outside evaluator would hold access equivalent to Anthropic's internal risk assessors. That puts pre-release model information in the hands of an organization outside the company.
- contradiction Yakovenko treats the $1 trillion figure as the explanation for the slowdown push. No company has confirmed any such link, so the current record cannot test both readings of motive.
The second stage is where the plan stops being something a company can do by itself. Amodei asked frontier developers in democratic countries to coordinate on common safety requirements and on limits for unchecked capability growth [10], and in the same essay he acknowledged that parts of that coordination could raise antitrust issues and might require narrow government authorization [11]. Competitors agreeing to hold capability back has the structure of the agreements competition law exists to police.
Stage one is Anthropic's alone to grant [9]. That leaves two of the three stages with parties outside the frontier labs [18]. Stage three needs other governments, and Amodei's essay contemplates agreements with China at several possible levels, running from restrictions on AI-assisted biological weapons to an eventual limit on rapid, automated model improvement [12].
David Sacks put his objection at the middle stage, arguing that laboratories could slow voluntarily without requiring a coordinated regulatory framework from competitors [6]. Voluntary pacing has no verification step. Verification is the reason Amodei himself ranked a comprehensive international pause as the least likely form of agreement to reach [13].
Yakovenko answered the whole debate in four words on Sept. 13: "Profitability at $1 trillion mcap." [7] [8] He did not say which company the figure referred to or show the revenue, valuation and profitability arithmetic behind it [8]. Anthropic and OpenAI are both privately held, so a market-capitalisation figure attached to either can only describe estimates from private transactions or a proposed listing [15]. Reuters reported that both were preparing for potential initial public offerings, without establishing that either had reached a $1 trillion market capitalisation or had made profitability contingent on that valuation [14], and no named company has confirmed that its support for slower development depends on reaching that number [17].
The incentive theory is the weaker of the two accounts. Amodei's stated reasons are model-control failures, cyber risks and the speed at which AI systems are helping create newer systems [16]. Yakovenko framed his post as a sarcastic observation, and he offered no evidence that Anthropic, OpenAI or xAI had coordinated their statements for financial reasons [19]. The antitrust caveat is the part of this that costs something. If the coordination ask turns into a legislative request with a defined exemption, pacing becomes a compliance cost that every frontier developer pays and that shows up in release schedules. If it stays in essays, the only thing that ships is the evaluator access Anthropic can grant on its own authority. Altman promised further implementation details soon [22].
What to watch
- Whether the coordination stage arrives as a specific legislative ask with a defined antitrust exemption, or stays at the level of essays and endorsements.
- The implementation details Altman promised, and whether they name which outside evaluators get employee-level access and on what schedule.
- Whether METR or another evaluator confirms it has received the ongoing, internal-equivalent access Anthropic described.